There was a Multidistrict Litigation (MDL) sought for all federal Darvon and Darvocet lawsuits as numerous lawsuits were filed against these drugs. New York resident Kristine Esposito, filed a petitionĀ in December 2010. Her attorneys filed a petition with the Judicial Panel on Multidistrict Litigation (JPML) to have all Darvon and Darvocet lawsuits to be consolidated for pretrial proceedings under judge Jack B. Weinstein, in the U.S. District Court for the Eastern District of New York.

Kristine Esposito of Queens, New York, sued Darvocet manufacturer inĀ the first ever lawsuit filed after FDA requested a withdrawal of all products containing the opiod painkiller propoxyphene. She sued Darvocet manufacturer alleging that Darvocet caused her to suffer from a severe cardiac arrhythmia and sought compensation for medical bills and other losses.

MDL would save the time and resources of the parties involved, their attorneys, witnesses, and the courts. It will also prevent contradictory pretrial rulings and duplicate discovery.

Xanodyne Pharmaceuticals (maker of Darvon and Darvocet) has filed a motion requesting denial of MDL. It argues that that the health of individual patients is a key determinant of the evidence and discovery gathered for the cases. Difference in the health conditions of patients makes MDL improper. Company can suffer from the liability of the generic versions of these drugs too. Xanodyne is currently facing only a handful of lawsuits. With MDL it has to face a whole bunch of cases. The company quickly complied with the FDA decision of withdrawal of these drugs to save itself from much litigation. Still many cases await it in coming months.

MDL against Darvon was to be decided in March 2011 but it is still pending. If it were approved then MDL would increase the efficiency of propoxyphene litigation. It will ensure a number of benefits for plaintiffs. This will save the time and resources of different individuals as the pretrial process in which parties gather and share information are coordinated in multiple similar cases before a single judge. It will also save money, as there is no need to file individual lawsuits for similar cases. It will also rule out inconsistency in ruling by clubbing many cases together.

You are eligible to file a Darvon or Darvocet lawsuit against Xanodyne or another manufacturer if you took a pain reliever containing propoxyphene and suffered a heart attack, stroke, arrhythmia, atrial fibrillation, or other cardiac injuries. You can demand compensation for the damage you suffered.

You can talk to good attorney and file a case against the manufacturer seeking compensation for your health damages and expenses on your treatment and other losses.